OPT News: Opthea strengthens its Board of Directors - 22nd Apr 2022, 10:15pm

annb0t

Top 20
Opthea Limited

Elects Mr. Quinton Oswald and Dr. Susan Orr, deeply experienced Ophthalmology Executives, at a General Meeting of Shareholders

MELBOURNE, Australia, April 22, 2022 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; Nasdaq: OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, today announced the appointment of Mr. Quinton Oswald and Dr. Susan Orr to its Board of Directors, effective immediately following...

>>> Read more: Opthea strengthens its Board of Directors
 
Top Bottom